Navigation Links
Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Multiple Myeloma
Date:8/3/2009

ical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. Keryx is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, a key signaling cascade that has been shown to induce cell growth and cell transformation. KRX-0401 has demonstrated both safety and clinical efficacy in numerous adult and pediatric tumor types, both as a single agent and in combination with novel therapies. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types, with a Phase 3 in multiple myeloma, under SPA, pending commencement. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release, particularly those anticipating future clinical trials and business prospects for KRX-0401, may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully and cost-effectively complete clinical trials for KRX-0401; the risk that the data (both safety and efficacy) from the Phase 3 study will not coincide with the d
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
2. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
4. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
5. Keryx Biopharmaceuticals Receives Nasdaq Notification
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
7. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
9. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
11. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 DMG Productions announces the ... to broadcast on Friday, May 29, 2015 at 7:30 ... , In this episode Innovations will explore Interstate Restoration, ... business quickly through disaster recovery and restoration. , Additionally, ... works collaboratively to develop and deliver training and education ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President ... selected by Consulting-Specifying Engineer (CSE) magazine as a young ... in the May/June issue of the publication. , This ... 40 and younger who have, and continue to make ... in other areas of their professional and personal endeavors. ...
(Date:5/22/2015)... A new program for the "In America" television ... Physical Therapy. , James Earl Jones will host ... physical therapy and discusses how the exercises can decrease ... of ailments and injuries. Physical therapists work with ... enhances daily activities such as house cleaning and shopping, ...
(Date:5/22/2015)... In efforts to offer full and robust ... muscles stretches has been a large focus over the ... complete, Chunk Fitness envisions a mid-June launch of these ... released at a later point in time. The current ... . , About the Company: Chunk Fitness was founded ...
(Date:5/22/2015)... Pro3rd Impression is a collection ... Cut Pro X. Pro3rd Impression's clean and simplistic layouts ... on-screen-controls allow users to customize scale, position and rotation ... much more can be edited using the controls located ... comes packed with 30 simplistically elegant lower thirds ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... During the current recession, small businesses turn to reflexology and aromatherapy, ... promote well-being and increase productivity. Scientific studies back the anecdotal evidence ... ... Colo. (PRWEB) January 5, 2009 -- Reflexology and Aromatherapy increase the ...
... Nepstar Chain,Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly ... Wade, a retail industry veteran,with an outstanding track ... the Company announced the appointment of Mr. William ...
... the snowy season , , SATURDAY, Jan. 4 (HealthDay News) -- ... as you take a few simple precautions, says the National ... on how to stay active and safe during cold weather ... constricts muscles, so you need to allow enough time for ...
... cancer prevention than vitamin supplementation. , ... Phoenix, AZ ... the Journal of the National Cancer Institute confirmed that vitamin supplementation ... study comes on the heels of numerous studies which all draw ...
... New Study Reveals the Most Common Reasons Why Total ... year thousands of patients undergo total hip replacement surgery ... hip disease and other related hip problems. According ... issue of The Journal of Bone and Joint ...
... Jan. 2 The owners of MAKE IT FIT(TM),( ... all Mississippians build healthier lifestyles in 2009 by donating,their ... Johnson,are offering all residents of the Magnolia state an ... if they sign up during the hours of,8am to ...
Cached Medicine News:Health News:Workplace Creativity Activated by Reflexology, Chair Massage 2Health News:Workplace Creativity Activated by Reflexology, Chair Massage 3Health News:China Nepstar Chain Drugstore Announces New Management Team Members 2Health News:China Nepstar Chain Drugstore Announces New Management Team Members 3Health News:China Nepstar Chain Drugstore Announces New Management Team Members 4Health News:Winter Workouts Are Cool 2Health News:Treadmill Desks More Effective in Cancer Prevention for Women than Vitamin C, E and Beta Carotene Supplementation 2Health News:Treadmill Desks More Effective in Cancer Prevention for Women than Vitamin C, E and Beta Carotene Supplementation 3Health News:Replacing Your Total Hip Replacement 2Health News:Replacing Your Total Hip Replacement 3Health News:MAKE IT FIT(TM) Offers Virtually Free Fitness Service to All Mississippi Residents on 'Make Mississippi Fit Day' 2
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
(Date:5/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that its Board of Directors has ... 2015 of $0.03 per share of common stock outstanding.  ... be paid on June 19, 2015 to all common ... ex-dividend date for the quarterly dividend is June 10, ...
(Date:5/21/2015)... , 21. Mai 2015 /PRNewswire/ ... DPRX ), ein Unternehmen für Arzneimittel ... die Entwicklung und Vermarktung von Locilex® ... kündigte heute eine wissenschaftliche Posterpräsentation an, ... des Unternehmens vorstellt, OneStep-1 und OneStep-2, ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... DIEGO , May 26 Anadys Pharmaceuticals, Inc. ... Lazard Freres & Co. LLC as its strategic advisor as ... stockholders from its non-nucleoside polymerase inhibitor, ANA598, in development for ... and antiviral response data at the conclusion of 12 weeks ...
... Agency,s consumer health information , , , ... May 26 The U.S. Food and Drug Administration announced today that it ... information. , , , ... , , ...
Cached Medicine Technology:Anadys Retains Lazard as Strategic Advisor 2Anadys Retains Lazard as Strategic Advisor 3Anadys Retains Lazard as Strategic Advisor 4Anadys Retains Lazard as Strategic Advisor 5FDA Announces Collaboration With Drugs.com 2
... used to evaluate both low contrast acuity and ... 12.5%) of LogMAR acuity (20/16 to 20/100) are ... the two spatial frequencies of 6 and 12 ... cataract documentation because eye doctors can document cataract ...
... test face is widely used for in or ... presents standard visual acuity from 20/15 to 20/200, ... cycles/degree) and a real-world driver's scene. , ,The ... it provides a standard acuity score, a functional ...
The compact, simple-to-use ECG for medical professionals....
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
Medicine Products: